Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Chiara Lazzari"'
Autor:
Chiara Lazzari
Publikováno v:
Labour & Law Issues, Vol 9, Iss 1, Pp 21-59 (2023)
The essay aims to examine the overall conceptual framework on which the legislative decree 9 April 2008 n. 81 is based upon. This decree is currently challenged by the definition of the concept of “workplace”, which is becoming increasingly flexi
Externí odkaz:
https://doaj.org/article/d0911ee5ee1c4d0a9524891800565688
Autor:
Chiara Lazzari, Calogera Claudia Spagnolo, Giuliana Ciappina, Martina Di Pietro, Andrea Squeri, Maria Ilenia Passalacqua, Silvia Marchesi, Vanesa Gregorc, Mariacarmela Santarpia
Publikováno v:
Current Oncology, Vol 30, Iss 4, Pp 3684-3696 (2023)
Lung cancer is the leading cause of cancer deaths in the world. Surgery is the most potentially curative therapeutic option for patients with early-stage non-small cell lung cancer (NSCLC). The five-year survival for these patients remains poor and v
Externí odkaz:
https://doaj.org/article/ae754c0014274db6a49f5cc62540ed43
Autor:
Gennaro Ciliberto, Marco Canfora, Irene Terrenato, Chiara Agnoletto, Francesco Agustoni, Loredana Amoroso, Gustavo Baldassarre, Giuseppe Curigliano, Angelo Delmonte, Antonella De Luca, Michelangelo Fiorentino, Vanesa Gregorc, Toni Ibrahim, Chiara Lazzari, Angela Mastronuzzi, Paolo Pronzato, Armando Santoro, Giovanni Scambia, Stefania Tommasi, Andrea Vingiani, Patrizio Giacomini, Ruggero De Maria
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-5 (2022)
Abstract Background Molecular tumor boards (MTBs) match molecular alterations with targeted anticancer drugs upon failure of the available therapeutic options. Special and local needs are most likely to emerge through the comparative analysis of MTB
Externí odkaz:
https://doaj.org/article/84b8b9ca44364bdc9a492d814dd3d47c
Autor:
Chiara Lazzari, Mona Rita Yacoub, Corrado Campochiaro, Alessandra Bulotta, Diego Palumbo, Francesca Rita Ogliari, Lorenzo Dagna, Silvia Marchesi, Maurilio Ponzoni, Vanesa Gregorc
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Hypereosinophilic syndrome (HES) represents a group of blood disorders characterized by an absolute eosinophil count (AEC) > 1.5 × 103/μl in the peripheral blood, which eventually extravasate and cause organ damage. It can be primary or secondary t
Externí odkaz:
https://doaj.org/article/793e50f9596b45d9af8946795fd0f08f
Autor:
Chiara Lazzari, Lorenza Pecciarini, Claudio Doglioni, Federica Pedica, Ana Maria Samanes Gajate, Alessandra Bulotta, Vanesa Gregorc, Maria Giulia Cangi
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Rearrangements involving the neurotrophin kinase (NTRK) genes NTRK1, NTRK2 and NTRK3 with different fusion partners have been observed in both adult and pediatric solid tumors. Larotrectinib and entrectinib have been the first tumor-agnostic compound
Externí odkaz:
https://doaj.org/article/6dd38d53ef6947b1a779a3dd317b252d
Autor:
Calogera Claudia Spagnolo, Giuliana Ciappina, Elisa Giovannetti, Andrea Squeri, Barbara Granata, Chiara Lazzari, Giulia Pretelli, Giulia Pasello, Mariacarmela Santarpia
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10119 (2023)
In recent years, we have seen the development and approval for clinical use of an increasing number of therapeutic agents against actionable oncogenic drivers in metastatic non-small cell lung cancer (NSCLC). Among them, selective inhibitors, includi
Externí odkaz:
https://doaj.org/article/8d5cbcb12fc84ae29f9d20b28638b6dc
Autor:
Lorenza Pecciarini, Emanuela Brunetto, Greta Grassini, Valeria De Pascali, Francesca Rita Ogliari, Anna Talarico, Giovanna Marra, Gilda Magliacane, Miriam Redegalli, Gianluigi Arrigoni, Chiara Lazzari, Vanesa Gregorc, Alessandra Bulotta, Claudio Doglioni, Maria Giulia Cangi
Publikováno v:
Cells, Vol 12, Iss 8, p 1135 (2023)
The ability to identify the broadest range of targetable gene fusions is crucial to facilitate personalized therapy selection for advanced lung adenocarcinoma (LuADs) patients harboring targetable receptor tyrosine kinase (RTK) genomic alterations. I
Externí odkaz:
https://doaj.org/article/4404556ae0164aec9fe83f1ca1c4212f
Autor:
Davide Valsecchi, Luca Porcu, Abdelrahman Khater, Rosa Alessia Battista, Leone Giordano, Stefano Cascinu, Andrea Assanelli, Chiara Lazzari, Vanesa Gregorc, Aurora Mirabile
Publikováno v:
Cancers, Vol 15, Iss 4, p 1240 (2023)
The coronavirus disease 2019 (COVID-19) pandemic has had a global impact. Patients with cancer, their caregivers, and physicians need to balance the challenges associated with COVID-19 while ensuring cancer care. Nevertheless, emotional distress and
Externí odkaz:
https://doaj.org/article/6f46fc069f2c4575a0ccf3de771e4530
Autor:
Priscilla Cascetta, Arianna Marinello, Chiara Lazzari, Vanesa Gregorc, David Planchard, Roberto Bianco, Nicola Normanno, Alessandro Morabito
Publikováno v:
Cancers, Vol 14, Iss 21, p 5430 (2022)
In NSCLC, KRAS mutations occur in up to 30% of all cases, most frequently at codon 12 and 13. KRAS mutations have been linked to adenocarcinoma histology, positive smoking history, and Caucasian ethnicity, although differences have been described acr
Externí odkaz:
https://doaj.org/article/b3f13472d0384ef9aec34b6277262a3d
Autor:
Ernesto Crisafulli, Nicol Bernardinello, Veronica Alfieri, Francesca Pellegrino, Chiara Lazzari, Letizia Gnetti, Alfredo Chetta
Publikováno v:
Respirology Case Reports, Vol 7, Iss 9, Pp n/a-n/a (2019)
Actinomycosis is a rare, chronic granulomatous infection, frequently associated with immunocompromised states, but it can also affect healthy people. Here, we report a case of a pulmonary infection by Actinomyces odontolitycus and Veillonella atypica
Externí odkaz:
https://doaj.org/article/4548420cf43d49b1a04f7bf576fd06bf